ArticleClinical cancer research : an official journal of the American Association for Cancer Research2008

Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.

Poonam R Molli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.